Clinical Trials in San Francisco

Showing 6381-6400 of 9,883 trials

Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma

NCT01290523

This is a prospective pilot study that will document the clinical experience of 30 patients with unresectable hepatocellular carcinoma undergoing liver-directed therapy with Yttrium-90 glass microspheres (TheraSphere®).

Hepatocellular Carcinoma

University of California, San Francisco14 participantsStarted May 2010

San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

NCT02217475

The purpose of this study is to determine whether cenicriviroc is effective and safe in the treatment of nonalcoholic steatohepatitis (NASH) in adult participants with liver fibrosis.

Nonalcoholic Steatohepatitis

Tobira Therapeutics, Inc.289 participantsStarted Sep 2014

Dothan, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +88 more locations

Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Find Trials by Condition in San Francisco

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

MEmbranous Nephropathy Trial Of Rituximab

The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis

Study of a Randomized Intervention Designed to Increase Exercise in Pregnancy

A Pilot Study of the Cala ONE Device for Essential Tremor

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Use of Mobile Apps for Those With PTSD and Their Partners

The Chimerix CMX001 Registry

Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Teaching Math Skills to Individuals With Fragile X Syndrome

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction